PPAR-independent peroxisome proliferators (Southeast TechInventures)

N/A

Report date: 2025/03/20 20:00:06

NME

Base Information

Drug NamePPAR-independent peroxisome proliferators (Southeast TechInventures)

Drug Alias Namenon-PPAR peroxisomal proliferators (Southeast TechInventures)peroxisome proliferator-activated receptor-independent peroxisome proliferators (Southeast TechInventures)

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsDiabetes Mellitus, Type 2Metabolic Dysfunction-Associated Steatotic Liver Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesSoutheast TechInventures Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesSoutheast TechInventures Inc

Active IndicationsN/A

Inactive IndicationsDiabetes Mellitus, Type 2Metabolic Dysfunction-Associated Steatotic Liver Disease

Other Information

ATC CodeN/A